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Minneapolis, MinnesotaABSTRACT Fluorescently labeledproteins that are foundboth in the cytoplasmandat theplasmamembrane, suchasperipheral
membrane proteins, create stratified fluorescent layers that present a challenging environment for brightness studieswith fluores-
cence fluctuation spectroscopy. The geometry of each layer along with fluorescence and brightness contributions from adjacent
layers generates a convoluted raw brightness that conceals the underlying brightness of each individual layer. Because the bright-
ness at a layer establishes the oligomeric state of the fluorescently labeled protein at said layer, we developed amethod that con-
nects the experimental raw brightness with the physical brightness at each layered compartment. The technique determines the
oligomerization in each compartment froman axial intensity scan through the sample, followed by a fluorescence fluctuation spec-
troscopymeasurement at each layer.Weexperimentally verify the techniquewithH-Ras-EGFPas amodel systemand determine
its oligomeric state at both the plasma membrane and in the cytoplasm. Furthermore, we study the oligomerization of the Gag
matrix domain of Human T-lymphotropic virus Type 1. The matrix domain targets the Gag polyprotein to the plasma membrane
where, subsequently, viral assembly occurs. We determine the oligomerization of matrix in the cytoplasm and observe the onset
of protein-protein interactions at the membrane. These observations shed light on the early assembly steps of the retrovirus.INTRODUCTIONPeripheral or extrinsic membrane proteins associate tempo-
rarily with the membrane to perform a variety of cellular pro-
cesses including signal transduction, cytoskeletal membrane
interactions, membrane trafficking, and enzymatic activities
like phospholipid metabolism and catabolism. Membrane
association and dissociation of peripheral membrane pro-
teins provide a mechanism for triggered conformational
changes that serve to regulate protein-protein interactions
and biological activity (1–5). This work introduces a method
based on fluorescence fluctuation spectroscopy (FFS) to
study the oligomeric state of peripheral membrane proteins
that reside in the cytoplasm and at the plasma membrane.
FFS techniques like fluorescence correlation spectroscopy
(6–8) and brightness analysis of fluctuations (9–11) have
been successfully used to study protein behavior both at
the membrane and in the cytoplasm of living cells (12–19).
Here, we focus on the use of brightness analysis for studying
the interactions of peripheral membrane proteins that reside
concurrently in the cytoplasm and at the plasma membrane.
Because peripheral membrane proteins associate revers-
ibly with the membrane, they often exist in two pools: a
membrane-bound form and a free soluble form in the cyto-
plasm. This leads to three distinct layers in a cell adherent to
a coverslip (see Fig. 1 A). The first layer consists of the basal
or bottom plasma membrane in contact with the glass. TheSubmitted February 28, 2014, and accepted for publication April 23, 2014.
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0006-3495/14/07/0066/10 $2.00second layer is the cytoplasmic compartment, followed by
the apical or top membrane as the last layer. The axial extent
of the optical excitation is much larger than the thickness of
the membrane, which ensures coexcitation of proteins in the
membrane-bound and cytoplasmic pools. The fluorescence
fluctuation contributions from both sources need to be dis-
entangled to reliably identify the brightness and oligomeric
state of proteins at the membrane and in the cytoplasm.
Z-scan FFS provides a method for untangling the fluores-
cence contributions of a multilayered protein system, and
allows the brightness of the sample at each layer to be estab-
lished. The technique was previously introduced to properly
account for fluorescence fluctuations in thin cytoplasmic sec-
tions (20) and is based off earlier work on z-scan fluorescence
correlation spectroscopy by Benda et al. (21). This study ex-
tends the theory of z-scan FFS to multiple strata, converts the
theoretical concepts into ameasurement strategy, and applies
z-scan FFS to peripheral membrane proteins. We investigate
the protein H-Ras as a model system and determine its olig-
omeric state at the plasma membrane and in the cytosol.
The Gag polyprotein plays a pivotal role in the assembly
and release of retroviruses (22). Recent studies indicated
fundamental differences between the early assembly events
of two retroviruses, human T-cell leukemia virus type 1
(HTLV-1) and human immunodeficiency virus type 1
(HIV-1) (23,24). Although HIV-1 Gag requires the onset
of cytoplasmic Gag-Gag interactions to promote transloca-
tion to the inner leaflet of the plasma membrane (25–27),
HTLV-1 Gag appears to engage the plasma membrane ashttp://dx.doi.org/10.1016/j.bpj.2014.04.055
FIGURE 1 Concept of z-scan FFS. (A) Three distinct cell layers: the bot-
tom membrane, cytoplasm, and top membrane. The axial length of optical
excitation (solid oval) leads to coexcitation of layers. (B) The slab model
defines the geometry by specifying the location of the bottom and top mem-
brane by zBM and zTM, respectively. The cytoplasmic layer extends from zBM
to zTM. The two-photon excitation spot is scanned along the z axis. (C)
Sketch of the average intensity for a cell expressing cytoplasmic EGFP
(solid line) and a membrane bound-EGFP fusion protein (dotted line).
(D) Q-parameter versus z position for the same parameters as panel C. To
see this figure in color, go online.
Z-Scan FFS of Multilayered Samples 67a monomer (24). Because the matrix (MA) domain of Gag is
the primary driver of Gag association with the inner leaflet
of the plasma membrane (28–32), this study investigates the
peripheral membrane protein MA by z-scan FFS to shed
light on the ability of HTLV-1 Gag to bind to the membrane
as a monomer and to identify its oligomeric state at the
membrane.MATERIALS AND METHODS
Experimental setup
Experiments were performed on a modified two-photon microscope, as pre-
viously described in Chen et al. (13). Detailed information about the exper-
imental setup, the sample preparation, plasmid construction, and brightness
analysis is found in the Supporting Material.Z-scan calibration
A z-scan calibration procedure was carried out to determine specific param-
eters of the modified squared Gaussian-Lorentzian point-spread function
(PSF) as described by Macdonald et al. (20). A series of eight z-scans
were performed on a cell expressing EGFP starting at the nucleus and
moving to thinner sections of the cell. A collective fit of the z-scan intensity
profiles using the PSF defined by Eq. 9 resulted in z0 ¼ 0.955 0.1 mm and
y ¼ 1.955 0.14 for a radial beam waist of w0¼ 0.47 mm. These values are
consistent with previously reported parameters (20) and will remain fixed
for the remainder of the experiment.Z-scan FFS procedure
In a three-layer protein system, an intensity trace is measured along the
z axis of the cell. A fit of the z-dependent intensity data provides the location
for the point FFS measurements: the bottom membrane layer zBM, the top
membrane layer zTM, and the midpoint of the cytoplasmic layer zmid ¼
(zBM þ zTM)/2. Point FFS measurements are then performed by focusing
the excitation PSF at zBM, zTM, and zmid. Movement of the cell or focus drift
during the FFS measurements would compromise the result. We performed
an intensity z-scan directly before and after the FFS measurement as a con-
trol. Changes in the intensity profile between the first and second z-scans
indicate the presence of motion. We only accepted FFS data for brightness
analysis when the intensity profiles agreed.Data analysis
The z-scan photon counts sampled at 20 kHz were rebinned by a factor of
80 by software, which corresponds to a z-scan sampling time of Tz ¼ 4 ms.
The z-scan speed vz ¼ 4.82 mm/s results in a step size Dz ¼ vzTz ¼ 19.3 nm
between binned photon counts kz. Fluorescence intensity was determined by
hF(z)i ¼ kz/Tz. Least-squares fitting of an experimental z-scan intensity pro-
file hF(z)i to Eq. 6 was accomplished by a Levenberg-Marquardt algorithm,
where the PSF parameters z0 and y were fixed to the experimentally deter-
mined values and the standard deviation of the binned photon counts was
estimated from the unbinned counts. The fit determined the position of
the bottom and top membrane (zBM, zTM) as well as the maximum fluores-
cence intensities of the bottom membrane, the top membrane, and the cyto-
plasm (FBM,max, FTM,max, and Fcyto,max).RESULTS
Z-scan FFS of a single layer
Scanning the two-photon excitation spot uniformly along
the z axis of a cell (Fig. 1 B) results in a z dependence of
the fluorescence signal (Fig. 1 C). For a cell expressing an
homogeneously distributed cytoplasmic protein like EGFP,
the first two moments of the fluorescence intensity have
been described previously by Macdonald et al. (20),
hFðzÞi ¼ l , hci ,V1ðzÞ;
hDF2ðzÞi ¼ l2hciV2ðzÞ: (1)
Thefluorescence intensity hF(z)i and variance hDF2(z)i of the
fluorescence depend on the cytoplasmic brightness l and con-
centration hci of the fluorescently labeled protein. The z
dependence is introduced by the generalized volume function
VrðzÞ ¼
Z
PSFrðr; zÞ , Sðzþ zÞ , 2pr dr dz;
which depends on the PSF raised to the rth power and the
sample shape factor S(z). The shape factor for a cytoplasmic
protein is given by a slab geometry starting at the bottom
plasma membrane (BM) and ending at the top plasma mem-
brane (TM). If we mark the location of both membranes by
zBM and zTM (Fig. 1 B), the shape factor of the cytoplasmic
protein is described by a Boxcar function starting at zBM and
ending at zTM,
SCytoðz; zBM; zTMÞ ¼

1; zBM<z<zTM
0; otherwise:
(2)Biophysical Journal 107(1) 66–75
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etry is depicted by the solid line in Fig. 1 C and reaches its
peak at midheight (zmid ¼ zBM þ zTM/2) of the slab, because
the volume overlap between the PSF and the sample is
maximized.
The fluorescence brightness l is determined from
Mandel’s Q-parameter (33,34),
QðzÞ ¼ hDF
2ðzÞi
hFðzÞi : (3)
By inserting Eq. 1 we show that Q is the product of the
brightness and a z-dependent gamma factor g2(z) ¼ V2(z)/
V1(z), as described previously, Q(z) ¼ g2(z) , l (20). The
z-dependent Q-parameter for the slab geometry is illustrated
by the solid line in Fig. 1 D. This is an extension of conven-
tional FFS, where the sample volume is considered to be in-
finite. Conventional FFS is characterized by a z-independent
Q-parameter, Q ¼ g2,N , l, where g2,N specifies the con-
ventional gamma-factor.Z-scan FFS of multiple layers
The above equations have been successfully applied to a sin-
gle geometric layer to determine the brightness of proteins
in thin cytoplasmic sections and to identify their stoichiom-
etry (20). In this article, we expand z-scan FFS to describe
geometries comprised of several layers. A simple example
of such a system is realized by a protein that resides both
in the cytoplasm and at the plasma membrane. We expect
that the presence of the protein at the plasma membrane
gives rise to two additional peaks in the intensity profile
(dotted line, Fig. 1 C) and the Q-parameter profile (dotted
line, Fig. 1 D), reflecting the contributions from fluorescent
proteins at the bottom and top plasma membranes.
To treat membrane-bound proteins and other complex
layered geometries requires a generalization of the theory
beyond that given in the previous section. Because the first
and second moments of the fluorescence intensity from
multiple independent sources are additive, for a multi-
layered sample the contributions from each layer are added
up to give the total average fluorescence intensity and its
variance as
hFðzÞi ¼ P
i
hFiðzÞi ¼
P
i
li , hcii ,V1;iðzÞ;
hDF2ðzÞi ¼ P
i

DF2i ðzÞ
 ¼ X
i
l2i , hcii ,V2;iðzÞ: (4)
The ith layer is described by its brightness li, concentration
hcii, and shape factor hSi(z)i, which make up the fluores-
cence intensity hFi(z)i and variance hFi2(z)i of the layer as
described in Eq. 1.
We are specifically interested in modeling proteins found
concurrently at the plasma membrane and in the cytoplasm.
This situation is best described by a three-layer system, con-Biophysical Journal 107(1) 66–75sisting of a bottom membrane (BM) located at ZBM, a cyto-
plasmic layer (Cyto), and a top membrane (TM) located at
ZTM. Because a membrane is much thinner than the linear
dimension of the PSF, its geometric shape factor is well
approximated by a delta-function. We refer to membranes
as delta layers to contrast their geometry with that of the
slab model used for the cytoplasm. Thus, the geometry is
described by SBM(z) ¼ d(z – zBM) for the bottom membrane
layer, STM(z) ¼ d(z – zTM) for the top membrane layer, and
SCyto(z; zBM, zTM) for the cytoplasmic layer.
The fluorescence intensity and fluctuations of a delta
layer are still described by Eq. 1, but with a reinterpretation
of some parameters. The volume concentration hci is re-
placed by the surface concentration hsi at the membrane
and the generalized volume function Vr(z) now represents
an area function (20). These changes are a consequence of
the delta-function and provide a rigorous interpretation of
z-scan intensity parameters.
The z-dependence of the fluorescence intensity of the
three-layer system is given by
hFðzÞi ¼ hFBMðzÞi þ

FCytoðzÞ
þ hFTMðzÞi: (5)
For fitting purposes, it is more convenient to express Eq. 5 ashFðzÞi ¼ FBM;max~vBMðzÞ þ FCyto;max~vCytoðzÞ þ FTM;max~vTMðzÞ;
(6)
where Fi,max represents the peak amplitude of the fluores-
cence profile hFi(z)i from the ith layer and ~viðzÞ is the scaled
volume function
~viðzÞ ¼ ViðzÞ=maxðViðzÞÞ:
The Q-parameter for the three-layer model is directly
computed from Eq. 4 by inserting the appropriate shape fac-
tor into the generalized volume function Vr,i(z),
QðzÞ ¼ g2;BMðzÞlBMfBMðzÞ þ g2;CytoðzÞlCyto fCytoðzÞ
þ g2;TMðzÞlTMfTMðzÞ: (7)
Each layer is specified by its Q-factor, Qi(z) ¼ g2,i(z) , li,
and fractional intensity, fi(z) ¼ hFi(z)i/hF(z)i. The total
Q-factor is given by summing the Q-factor of each layer
weighted by its fractional intensity fi(z).
It is convenient to report the brightness of each layer li as
a normalized value by comparing it to the brightness lEGFP
of EGFP, bi ¼ li/lEGFP. A normalized brightness bi ¼ 1 in-
dicates a monomeric protein, whereas bi ¼ 2 indicates a
dimer in the ith layer. For measurements of stoichiometry,
it is helpful to convert the Q-factor into a z-dependent
normalized brightness bbðzÞ by dividing Q(z) by the bright-
ness of EGFP and the conventional gamma factor g2,N,
bbðzÞ ¼ mBMðzÞfBMðzÞbBM þ mCytoðzÞfCytoðzÞbCyto
þ mTMðzÞfTMðzÞbTM; (8)
Z-Scan FFS of Multilayered Samples 69where we introduced the gamma factor ratio mi ¼ g2,i/g2,N.
We stress that bBM, bTM, and bCyto are the proper brightness
values of the three layers. However, these values are not
directly experimentally accessible. The experimental bright-
ness bbðzÞ at each z position is a complex composite contain-
ing the brightness from each layer. Because bbðzÞ requires
further processing to extract the oligomeric state of proteins
at each layer, we refer to it as ‘‘raw brightness’’ throughout
the rest of the article.FIGURE 2 The z-dependent fluorescent intensity profile in kilo counts/s.
(A) The profile (solid line) from EGFP-H-Ras and its fit (shaded line) to
Eq. 6 (reduced c2 ¼ 1.4). (Dotted-dashed line) Contribution from the cyto-
plasmic (slab) layer; (dotted lines) contribution from the membrane (delta)
layers. (B) The intensity profile (solid line) from the combined fluorescence
of EGFP-H-Ras and mCherry and its fit (shaded line) to Eq. 6 (reduced
c2 ¼ 1.3). The increase in the cytoplasmic intensity (dotted-dashed line)
stems from the addition of the mCherry signal. To see this figure in color,
go online.Experimental intensity profiles of multiple layers
Applying the above theory to experimental data requires
one more crucial ingredient, the PSF, because it connects
the shape factor with the generalized volume function
Vr(z). The experimental PSF is commonly approximated
by either the three-dimensional Gaussian function or the
squared Gaussian-Lorentzian function. However, neither
of these functions sufficiently approximates the axial pro-
file of our PSF. We chose to model experimental z-scan
data with the modified squared Gaussian-Lorentzian func-
tion (20)
PSFmGLðr; zÞ ¼

z20
z20 þ z2
ð1þyÞ
exp

 4z
2
0
w20
r2
z20 þ z2

: (9)
The radial and axial beam waist are characterized by w0 and
z0, whereas y adjusts the axial decay of the PSF. The z0 and y
parameters of the PSF were determined experimentally, as
described in Materials and Methods.
The plasma membrane protein EGFP-H-Ras expressed in
U2OS cells served as a multilayer test system. The z-depen-
dent intensity trace shows a distinct double peak (see Fig. 2
A, solid line), suggesting that the protein is predominantly
located at the cell membrane. We initially fit the experi-
mental intensity profile with a two-layer model by setting
hFCyto(z)i in Eq. 5 to 0. The result of this fitting was unsat-
isfactory, because systematic deviations between data and
model were observed (reduced c-squared of 2.8). We sus-
pected that the misfit was caused by the presence of
cytoplasmic EGFP-H-Ras. We removed the constraint
hFCyto(z)i ¼ 0 and successfully refit the EGFP-H-Ras inten-
sity profile with the general three-layer model. The fit
(Fig. 2 A, shaded line) shows no systematic deviations and
has a reduced c-squared of 1.4. In fitting the data, informa-
tion was obtained about the z-dependent intensity for the
cytoplasmic component (dotted-dashed line), the z-depen-
dent intensities from the membrane components (dotted
lines), and cell height h ¼ zTM – zBM. Because the cyto-
plasmic contribution to the signal was small, EGFP-H-Ras
is a useful model system for a predominantly membrane-
bound protein distribution.
Finally, we varied the ratio of cytoplasmic to membrane-
bound protein by coexpressing mCherry and EGFP-H-Ras
in U2OS cells. The mCherry protein populated the cyto-plasmic pool, whereas EGFP-H-Ras contributed mainly to
the membrane-bound component. Expressing two differ-
ently colored fluorescent proteins provided a convenient
method to quickly select transfected cells expressing each
protein at the desired intensity ratio. Although the fluores-
cence was split into a green and a red detection channel,
we combined the photon counts of both channels in software
to mimic the fluorescence signal of a single-colored fluores-
cent protein found in the cytoplasm and at the membrane.
The z-scan intensity profile (solid line) of the combined
signal from a coexpressing cell is shown in Fig. 2 B together
with a successful fit (shaded line) of the data by Eq. 6 with a
reduced c-squared of 1.3. Although the additional presence
of mCherry made the cytoplasmic intensity more prominent
than in Fig. 2 A, each membrane layer along with the cyto-
plasmic layer was still cleanly resolved by the fit. Thus, the
three-layer model successfully described the z-dependent
intensity profiles for proteins with membrane-bound and
cytoplasmic populations.Brightness measurements in multilayer protein
geometries
Before taking brightness measurements, it is illustrative to
consider the influence of the three-layer geometry on the
raw brightness by studying the z-dependence of Eq. 8 forBiophysical Journal 107(1) 66–75
70 Smith et al.a few select cases. For a purely cytoplasmic monomeric pro-
tein, such as EGFP, Eq. 8 reduces to
bbðzÞ ¼ mCytoðzÞ , bCyto
with bCyto¼ 1. The corresponding raw brightness curve (see
Fig. 3 A, shaded line) for a thick (5-mm) cytoplasmic layer
approaches 1 as the focus of the beam reaches the center of
the sample where mcyto ¼ 1, because the entire PSF is
embedded in the sample. These are the conditions where
conventional FFS, which ignores sample geometry, is valid.
Next, consider a monomeric protein only found at the
bottom plasma membrane, which simplifies Eq. 8 to
bbðzÞ ¼ mBMðzÞ , bBM
with bBM¼ 1. The brightness curve (Fig. 3 A, solid line) has
a single peak with a maximum at the position of the bottom
membrane. We notice that the raw brightness at the bottom
membrane exceeds 1. This increase is caused by the sample
geometry, which is reflected in the gamma factor ratio mBM
(zBM) ¼ g2,BM (zBM)/g2,N. In fact, one may think of the
gamma factor ratio mi(z) as the bias factor in brightness
due to sample geometry. The bias factor of a delta layer
is mBM (zBM) z 1.8 for our PSF. Thus, conventional FFSFIGURE 3 Modeling of raw brightness bb as a function of z position. (A)
The raw brightness is calculated assuming a cell with a height of 5 mm.
(Shaded line) bbðzÞ for EGFP in a cell. (Solid and dashed lines) bbðzÞ for a
monomeric membrane protein labeled with EGFP located at either the bot-
tom or top plasma membrane. (B) The raw brightness bbðzÞ is calculated
assuming a cell with a height of 3 mm and a monomeric protein distributed
between the cytoplasm and the plasma membrane with an intensity ratio of
FBM,max: FCyto,max: FTM,max of 3:1:3. The raw brightness in the cytoplasm
and also at the plasma membrane is suppressed as compared to panel A
due to the coexcitation of fluorescent proteins across adjacent sample
layers.
Biophysical Journal 107(1) 66–75analysis of a protein at the membrane overestimates bright-
ness by ~1.8 due to the thin geometry. The raw brightness
curve for a monomeric protein at the top membrane
(Fig. 3 A, dashed line) is identical to that of the bottom
membrane except for a shift in the z-position, reflecting
the different location of the membrane.
The general case involves proteins occupying the cyto-
plasm and the membranes. The resulting raw brightness
curve is, according to Eq. 8, the superposition of the raw
brightness curve from each layer (Fig. 3 A) weighted by
its fractional intensity fi(z). The dependence of the raw
brightness bbðzÞ on the fractional intensity, the geometric
bias factor, and the brightness of each layer, leads to a con-
voluted signal that is not straightforward to interpret. We
illustrate this point in Fig. 3 B by plotting Eq. 8 for a slab
with a thickness of 3 mm with monomeric EGFP (bBM ¼
bCyto ¼ bTM ¼ 1) distributed among the bottom membrane,
the cytoplasm, and the top membrane with an intensity ratio
FBM,max/FCyto,max/FTM,max of 3:1:3. We see that the raw
brightness peaks at the membranes are reduced as compared
to the value of 1.8 expected for a monomeric protein at the
membrane, as discussed earlier. The raw brightness at the
center of the cytoplasmic slab is less than the expected value
of 1. Thus, quantitative analysis of the raw brightness curve
is essential to link bbðzÞ to the actual brightness of each layer.
Measuring the complete raw brightness curve bbðzÞ and
fitting it to Eq. 8 is very time-consuming, because an FFS
measurement at a single z-position takes tens of seconds.
A closer look at Eq. 8 reveals that measuring bbðzÞ at three
different locations (zBM, zTM, and zmid) is sufficient to calcu-
late the brightness of each layer (bBM, bCyto, and bTM). The
additional information needed for Eq. 8 is obtained by a fit
of the intensity profile hF(z)i, which provides the fluores-
cence signal hFi(z)i from each layer as well as the location
(zBM, zTM) of the membrane layers. This information serves
to calculate the gamma factor ratios and fractional inten-
sities that appear in Eq. 8. For the three raw brightness
values bbðzÞ, we chose to measure at the bottom membrane,
at the top membrane, and at midheight in the cytoplasm. The
experimental values bbðzBMÞ, bbðzTMÞ, and bbðzmidÞ together
with the fit of the intensity profile hF(z)i and Eq. 8 supply
three equations
0
@ bbðzBMÞbbðzmidÞbbðzTMÞ
1
A ¼
0
@ aBMðzBMÞ aCytoðzBMÞ aTMðzBMÞaBMðzmidÞ aCytoðzmidÞ aTMðzmidÞ
aBMðzTMÞ aCytoðzTMÞ aTMðzTMÞ
1
A

0
@ bBMbCyto
bTM
1
A;
(10)
where the matrix elements are given by ai(z) ¼ mi(z)fi(z).
Inverting the above equation determines the parameters
bBM, bCyto, and bTM.
Z-Scan FFS of Multilayered Samples 71To test multilayer brightness analysis at the plasma mem-
brane, cells expressing the membrane protein EGFP-H-Ras
were used as an experimental trial system. An intensity
z-scan was followed by point FFS measurements at the
top plasma membrane (zTM), the bottom plasma membrane
(zBM), and in the cytoplasm (zmid). The brightness values
measured at the top and bottom membrane exceeded 1,
and brightness measured in the cytoplasm scattered between
0.3 and 1 (see Fig. 4 A). By analyzing the raw brightnessbbðzÞ as described above, we identify the brightness from
each layer (Fig. 4 B). The analysis reveals that in U2OS
cells, EGFP-H-Ras is monomeric both at the membrane
and in the cytoplasm for all measurements.
We provide a detailed analysis of two separate z-scan FFS
experiments performed on cells expressing EGFP-H-Ras to
illustrate the dependence of bbðzÞ on geometry. The bottom
panel of Fig. 4 C shows the intensity profile of a cell with
a wider separation of the membranes than the cell in
Fig. 4 D. After fitting the intensity profile of both cells,
the raw brightness curves bbðzÞ were calculated assuming a
brightness of 1 at the membrane and in the cytoplasm.
Thus, the raw brightness curves shown in the top panels of
Fig. 4, C and D, represent the case of monomeric EGFP-FIGURE 4 Z-scan brightness analysis in U2OS cells expressing EGFP-H-Ras
circles) and bottom (solid circles) membrane versus the fluorescence intensity
brightness bbðzmidÞ from the midpoint in the cytoplasm (open triangles) (mean
bmembrane at the top (shaded circles) and bottom (solid circles) membrane (mean a
in the cytoplasm (mean and SD of 1.015 0.06). (C andD) EGFP-H-Ras z-scan p
in kilo counts/s (solid line) and fit (shaded line) along with the fitted profiles from
zmid, and zTM. The raw brightness curves (solid line) are generated for the lower-p
in the cytoplasm. (E) Z-scan FFS experiment of a cell expressing EGFP-H-Ras a
in color, go online.H-Ras, and the measured brightness values bb (shaded
dots) at the membranes and in the center of the cytoplasmic
slab are in good agreement with the raw brightness curve.
The raw brightness bb at the membrane in Fig. 4, C and D,
is close to the value of 1.8. The slight reduction in brightness
reflects the coexcitation of cytoplasmic protein that leads to
a drop in the fractional intensity at the membrane. Because
the intensity contributions from the cytoplasm are small, the
decrease in the fractional intensity at the membrane is minor
and the raw brightness bb predominantly reflects the bright-
ness of a purely membrane-bound protein enhanced by the
geometric bias factor of 1.8 (see Fig. 3 A).
The raw brightness bbðzmidÞ in the cytoplasm, on the other
hand, is significantly affected by the thickness of the cell at
the position of the z scan. Although a thick slab (Fig. 4 C)
leads to very little suppression of bb due to contributions of
the membrane signal, a thinner slab (Fig. 4 D) leads to a
significant reduction in bb. This coexcitation dependence
on brightness is largely responsible for the scatter in the
measured raw brightness values of Fig. 4 A.
The coexcitation dependence also affects the brightness at
the membrane when a large relative pool of protein exists
in the cytoplasm. Because cytoplasmic protein levels for. (A) (Top panel) Raw brightness bbðzmembraneÞ measured at the top (shaded
(mean and standard deviation (SD) of 1.72 5 0.13). (Bottom panel) Raw
and SD of 0.59 5 0.22). (B) (Top panel) True EGFP-H-Ras brightness
nd SD of 1.005 0.06); (bottom panel) true brightness bcyto (open triangles)
lots for two cells with different thicknesses. (Bottom panels) Intensity traces
each layer. (Top panels) Measured raw brightness (shaded circles) at zBM,
anel intensity curves assuming monomeric proteins at both membranes and
nd EGFP. The graphs and labeling are identical to panel C. To see this figure
Biophysical Journal 107(1) 66–75
72 Smith et al.EGFP-H-Ras alone were relatively low, we demonstrated
this effect by increasing the pool of cytoplasmic fluorescent
proteins through coexpression of EGFP and EGFP-H-Ras.
Fig. 4 E shows the z-scan FFS analysis of a cell expressing
both proteins in which the fluorescence of the cytoplasmic
pool (Fig. 4 E, bottom panel) is much larger than for
EGFP-H-Ras alone. This leads to a significant reduction
of the raw brightness at the membrane position from the
value of 1.8 (Fig. 4 E, top panel), because the larger cyto-
plasmic fluorescence introduces a pronounced drop in the
fractional intensity of the membrane signal.FIGURE 5 MA domain of retroviral Gag proteins. (A) Normalized inten-
sity of HIV-1 MA-EGFP (light dotted line) and fit (shaded line) to cyto-
plasmic slab model and of HTLV-1 MA-EGFP (dark dotted line) and fit
(solid line) to Eq. 6. (B) Brightness and intensity data from a cell expressing
HTLV-1 MA-EGFP. The raw brightness (shaded circles) taken at the bot-
tom membrane, cytoplasm, and top membrane (top panel) together with
a modeled brightness curve generated for the intensity trace (bottom panel)
assuming a monomeric protein in the cytosol and a dimeric protein at the
plasma membrane. (C) Brightness from a population of cells expressing
HTLV-1 MA-EGFP. The brightness at the membrane (solid circles) as a
function of areal protein density (mm2) shows a concentration-dependent
monomer to dimer transition. Dimer binding curve (solid line) with a disso-
ciation coefficient of ~300 mm2 and510% error bounds (dotted lines) for
brightness at the membrane. The brightness in the cytoplasm (shaded trian-
gles) as a function of volume protein density (mm3) is monomeric at all
measured concentrations. To see this figure in color, go online.Matrix domain of HTLV-1 Gag
Although assembly of the retrovirus requires the full-length
Gag protein, the process is complex and involves hundreds-
to-thousands of Gag copies that pack together into individ-
ual Gag puncta. We chose to simplify the problem by
investigating the MA domain of Gag inasmuch as MA is
the primary driver of Gag association with the inner leaflet
of the plasma membrane, but it lacks the ability to multimer-
ize into large complexes (30,32). We first assessed the
potential of MA-EGFP to bind to the plasma membrane.
Z-scans were performed on U2OS cells transiently express-
ing either HTLV-1 MA-EGFP or HIV-1 MA-EGFP. Visual
inspection of the z-scan intensity trace from each protein
(see Fig. 5 A) identified distinct differences in behavior.
HIV-1 MA-EGFP (shaded line) appears to be a cytoplasmic
protein, whereas HTLV-1 MA-EGFP (solid line) has a sig-
nificant membrane-bound component, as indicated by the
double peak in the intensity profile.
A fit of the data to the three-layer model confirmed that
the HIV-1 MA-EGFP trace has no detectable protein com-
ponent at the membrane, whereas HTLV-1 MA-EGFP has
the majority of its intensity coming from the membrane, sug-
gesting a strong plasma membrane component. Repeating
z-scan measurements on cells expressing the protein at
various concentrations confirmed these observations (data
not shown). HIV-1MA-EGFP is only found in the cytoplasm,
whereas HTLV-1 MA-EGFP has a significant membrane-
bound component. Although we often observed differences
in the intensity peaks at the top and bottom membrane,
there was no systematic trend favoring one membrane over
the other. The differential binding of MA to the plasma
membrane for these two retroviruses agrees with a previous
study (24).
Raw brightness measurements were taken for HIV-1
MA-EGFP in the cytoplasm and z-scan FFS analysis, as
previously described for a single layer, and were used to
determine the cytoplasmic brightness (20). HIV-1 MA-
EGFP displayed monomeric brightness at all concentrations
(data not shown). This is consistent with the literature,
which suggests that the HIV-1 MA protein does not exhibit
appreciable homo-interactions at physiological concentra-
tions (35,36). For HTLV-1 MA-EGFP, we measured rawBiophysical Journal 107(1) 66–75brightness bb values at both plasma membranes and at the
midsection in the cytoplasm (Fig. 5 B). The top panel of
Fig. 5 B shows the raw brightness bb (shaded dots) as well
as a theoretical raw brightness curve determined from the
z-intensity trace (bottom panel). We note that bb at the mem-
brane exceeds 1, whereas bb in the cytoplasm is typically<1,
which reflects the multilayer nature of the sample. For this
specific HTLV-1 MA-EGFP measurement, the raw mem-
brane brightness bb exceeded 3, which suggested the pres-
ence of protein-protein interaction at the membrane. After
applying Eq. 10 to the raw brightness values, we determined
that the true brightness values are bBM ¼ 1.97 5 0.21,
bTM ¼ 1.97 5 0.21, and bcyto ¼ 1.06 5 0.12.
To further study the behavior of HTLV-1MA-EGFP at the
plasma membrane, we performed z-scan FFS measurements
on a population of cells with varying HTLV-1 MA-EGFP
Z-Scan FFS of Multilayered Samples 73concentrations. We applied the matrix analysis of Eq. 10 to
the experimental bb data to isolate the membrane brightness
(bBM, bTM) and cytoplasmic brightness (bCyto) of the tagged
HTLV-1 MA protein (Fig. 5 C). The cytoplasmic brightness
bCyto is concentration-independent, bcyto 1.01 5 0.12. The
brightness of HTLV-1 MA-EGFP at the plasma membrane,
on the other hand, exhibits a concentration-dependent
increase from ~1 at low concentration to a value of 2 at
high concentration. Thus, the data reveal that HTLV-1
MA-EGFP undergoes a monomer-to-dimer transition with
the solid line representing a binding curve with a dimeriza-
tion dissociation coefficient of ~300 molecules/mm2.FIGURE 6 The modeled raw brightness bbðzBMÞ at the bottom membrane
is given as a function of the fractional intensity fBM(zBM) for a cell with both
membrane-bound and cytoplasmic protein populations. bbðzBMÞ was
modeled for monomeric, dimeric, and trimeric protein at the membrane,
while keeping the cytoplasmic protein a monomer in all cases. The raw
brightness bbðzBMÞ decreases as a function of fractional intensity in all cases
but decreases more rapidly as the brightness difference between the cyto-
plasm and membrane increases. To see this figure in color, go online.DISCUSSION
Our results demonstrate that properly identifying the bright-
ness of fluorescently-labeled proteins found both at the
plasma membrane and in the cytoplasm is challenging. A
few earlier studies have noted that fluorescence from neigh-
boring layers qualitatively affects the measured brightness
(37–39). In addition, brightness bias at the membrane due
to delta-layer geometry was mentioned, but could not be
experimentally identified (40). This study demonstrates
that there are primarily three factors that confound quantita-
tive interpretation of brightness measurements: the geome-
try of the layer, the intensity contribution from adjacent
layers, and the brightness of adjacent layers. We briefly
discuss each of these factors.
The first factor is the geometric effect, which for a strat-
ified layer boils down to the thickness of each layer. When
applying conventional FFS, a layer that is thinner than the
axial length of the excitation PSF will lead to an increase
in the raw brightness as originally reported by Macdonald
et al. (20). In the extreme case of a delta layer, as is used
to describe the plasma membrane, the raw brightness is
increased by ~1.8 for our excitation PSF.
The second factor accounts for the presence of back-
ground fluorescence from neighboring layers. The fluores-
cence signal of a layer is diluted by this background
signal, which lowers the fractional intensity and thereby
the raw brightness.
The third factor accounts for differences in brightness at
neighboring layers. To illustrate its effect, we used Eq. 8
to calculate the raw brightness bbðzBMÞ at the bottom mem-
brane as a function of the fractional intensity fBM(zBM) for
a cell with both membrane-bound and free cytoplasmic pro-
tein populations (see Fig. 1 A). In Fig. 6, we systematically
changed the actual brightness at the membrane from a
monomer to a trimer, while keeping the cytoplasmic protein
as a monomer in all cases. The raw brightness bb decreases as
a function of fractional intensity for all cases, but the slope
differs significantly. In general, a larger brightness differ-
ence between the cytoplasmic and membrane-bound protein
leads to a steeper drop in raw brightness with fractional in-
tensity. This issue is significant because membrane bindingfrequently promotes oligomerization of the protein at the
membrane whereas the cytoplasmic fraction remains in
monomer form. Thus, the fluorescence background from
the cytoplasm and the brightness difference between the
membrane-bound and cytoplasmic fractions lead to a
reduced measured brightness at the membrane, which ham-
pers the proper identification of the oligomeric state.
Although this work used a Gaussian-Lorentzian PSF
model for fitting the data, it is important to emphasize that
the z-scan method is not tied to any particular PSF model.
The only requirement is an accurate parameterization of
the experimental PSF. Extension of the z-scan method to
one-photon excitation only requires a proper parameteriza-
tion of the one-photon PSF. To be more precise, one-photon
excitation uses the observation volumeO(r, z) instead of the
PSF to account for the effect of the pinhole on the collected
fluorescence emission. This observation volume can be
modeled by multiplying the excitation PSF by a collection
profile function (41). Once a proper parameterization of
O(r, z) has been obtained, z-scan analysis with one-photon
excitation can be performed by replacing the PSF of Eq. 9
with O(r, z).
If a protein resides exclusively at the plasma membrane,
then the problem reduces to a single layer, provided the top
and bottom membrane are sufficiently far apart to avoid
coexcitation. In this case, the brightness of a protein at the
plasma membrane can be measured directly (38,39,42).
Relating the measured brightness with the oligomeric state
of the protein relies on a calibration experiment with a
monomeric membrane protein to identify the monomeric
brightness value. H-Ras appears to be an acceptable mono-
meric brightness standard for U2OS cells, but we observed
both monomeric and higher brightness states for EGFP-H-
Ras in MDCK cells (data not shown). It was recentlyBiophysical Journal 107(1) 66–75
74 Smith et al.reported that H-Ras was found in both monomeric and clus-
ter form at a ratio of 70:30 for each respective species (43) in
BHK cells. Thus, identifying a brightness standard for mem-
brane measurements appears challenging, because the cell
line and cell environment can potentially alter the oligomer-
ization and clustering of the protein.
To avoid these potential complications, we suggest a
straightforward alternative to establish the monomeric
brightness at the membrane. A routine measurement of the
fluorescent protein in the cytoplasm or nucleoplasm deter-
mines the true monomeric brightness lmonomer. We account
for the delta-layer geometry of the membrane by multi-
plying lmonomer by the geometric bias factor mM(zM) for a
membrane, which is calculated as described earlier. The
product
blmonomer ¼ mMðzMÞlmonomer
represents the calibration brightness for a monomer at the
membrane. This calibration procedure works as long as
the brightness near the membrane and in the cytoplasm
are the same. A constant brightness is an essential property
of any fluorescent protein suited for quantitative brightness
experiments and needs to be established independently for
each new fluorescent label (44). For example, EGFP has a
stable brightness that remains unchanged when tagged to
another protein, as well as, when measured in the nucleus,
cytoplasm and in vitro (12,44). As expected and shown by
our data, the brightness of EGFP at the plasma membrane
and in the cytosol is the same as long as geometry is
accounted for. Thus, the above calibration procedure should
prove useful for any fluorescent protein suited for quantita-
tive brightness experiments.
Fluorescence from neighboring layers also affects the raw
brightness in the cytoplasm, although this issue has not
received much attention yet. A 2011 study observed un-
physically low brightness values in the cytoplasm when
studying HIV-1 and HTLV-1 Gag interactions in cytoplasm
(23), which were traced back to the presence of fluorescence
from a membrane-bound fraction of labeled Gag proteins.
Here we observed the same phenomenon for H-Ras
(Fig. 4 A) and HTLV-1 MA (Fig. 5 B). However, unlike
the earlier study we used quantitative z-scan FFS to identify
the correct brightness in the cytoplasm and at the membrane.
Studying the MA domains of both HIV-1 Gag and HTLV-1
Gag revealed a purely cytosolic distribution of HIV-1 MA-
EGFP, while HTLV-1 MA-EGFP was distributed between
the cytoplasm and the plasma membrane, which agrees
with recent observations (24) and implies fundamental dif-
ferences between the early steps in HIV-1 and HTLV-1
assembly.
Our study further provides evidence that cytoplasmic
HTLV-1 MA-EGFP binds the plasma membrane as a mono-
mer, because HTLV-1 MA-EGFP was entirely monomeric
in the cytoplasm and only exhibited a concentration-depen-Biophysical Journal 107(1) 66–75dent monomer to dimer transition at the plasma membrane.
This observation is supported by immunoprecipitation and
immunoblotting studies that identified the presence of stable
MA dimers at the plasma membrane (45). Because we
measure both cytoplasmic and membrane-bound pools of
HTLV-1 MA-EGFP, our brightness data provide evidence
that links the monomeric MA in the cytoplasm with the
observed dimers at the membrane through the presence of
MA-MA interactions that occur in the membrane-bound
form. Of course, dimerization is only the first step toward
assembly of the complete viral-like particle. Observing
additional steps requires future experiments with the full-
length Gag protein to account for the additional interactions
outside the MA domain that play a role in the formation of
high-order Gag complexes (46). The advances in brightness
experiments presented here not only provide the foundation
for future work with the full-length HTLV-1 Gag protein,
but also should prove useful for studies of any protein that
is distributed across stratified layers within the cell.SUPPORTING MATERIAL
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